Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06823089 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Early Feasibility Study of Cartilage Defect Repair

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 4 more changesShow less
    • Eligibility criteria expanded, about 34 words
    • Secondary endpoints: details revised at 1 of 7 entries
    • Site details revised
    • Publications: details revised at 2 of 2 entries
  2. Site contact updatedv5
  3. Trial status: Enrolling by Invitation to Recruiting
    • Eligibility criteria expanded, about 46 words
    • Secondary endpoints: 8 to 7
    • Site details revised
    v4
  4. Trial status: Not Yet Recruiting to Enrolling by Invitationv3 Show 6 more changesShow less
    • Primary completion date: Apr 2028 to Oct 2031
    • Start date changed from estimate of Apr 2025 to Nov 6, 2025
    • Primary endpoints revised (2)
    • Study sites: 0 to 1
    • Study completion date: Apr 2031 to Oct 2031
    • Eligibility criteria expanded, about 1 word
  5. Primary completion date: Mar 2028 to Apr 2028
    • Study completion date: Mar 2031 to Apr 2031
    • Start date: Mar 2025 to Apr 2025
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Any patient aged 14 or older up to 64 years of age with hip disease, resulting in loss of articular cartilage integrity on the femoral head (e.g., femoroacetabular impingement or other structural deformity), has failed conservative care, and is a candidate for surgical intervention to treat.
Trial Details
NCT Number NCT06823089
Lead Sponsor Cytex Therapeutics, Inc.
Collaborators: MCRA
Conditions
(from sponsor)		 Osteoarthritis, Hip, Femoroacetabular Impingement, Osteonecrosis, Legg-Calvé-Perthes Disease, Osteochondral Lesion, Hip Dysplasia
Related terms Coxa Magna, Femoracetabular Impingement, Femur Head Necrosis, Hip Dislocation, Legg-Calve-Perthes Disease, Osteoarthritis, Hip, Osteonecrosis
Enrollment 15 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov